11d
Zacks.com on MSNUBX Stock Down 29% on Mixed Results From Phase II Eye Disease StudyUNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical ...
Image Source: Zacks Investment Research ... with no reported cases of intraocular inflammation, retinal artery occlusion, endophthalmitis or vasculitis. UNITY Biotechnology expects to report ...
4d
News-Medical.Net on MSNThe evolution of OCT for retinal imaging and disease interventionDr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the ...
A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.
Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration.
Retinal regeneration and visual recovery in a retinitis pigmentosa model mouse through administration of AAV2-Anti-PROX1 gene therapy. We demonstrate that after administration of adeno-associated ...
1don MSN
Scientists have for the first time looked deep into the protein structure that may determine our vision—and discovered that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results